90 related articles for article (PubMed ID: 20132175)
1. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A
APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of iNOS in epithelial ovarian cancer.
Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
[TBL] [Abstract][Full Text] [Related]
5. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
Chen HH; Su WC; Chou CY; Guo HR; Ho SY; Que J; Lee WY
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1093-100. PubMed ID: 16099602
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma.
Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
Oncol Rep; 2002; 9(3):521-4. PubMed ID: 11956620
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma SH; Lipponen PK; Kosma VM
Anticancer Res; 2001; 21(4B):3101-6. PubMed ID: 11712818
[TBL] [Abstract][Full Text] [Related]
11. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
13. [Inducible nitric oxide synthase and basic fibroblast growth factor expression as prognostic factors in supraglottic squamous cell carcinoma].
Huang Z; Zeng ZY; Peng HW; Xia LP; Hou JH
Ai Zheng; 2003 Sep; 22(9):978-81. PubMed ID: 12969533
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
18. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in stage II colorectal carcinoma.
Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
